M. Meurer

Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study

N. André, E. Pasquier, K. MacKenzie, 2016, EBioMedicine.

Risk and protective factors for sporadic basal cell carcinoma: results of a two‐centre case–control study in southern Germany. Clinical actinic elastosis may be a protective factor

U. Walther, R. Peter, P. Kaskel, 2004, The British journal of dermatology.

Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group

J. Blay, F. Bertucci, S. Salas, 2019, International Journal of Gynecologic Cancer.

Prognostic Value of the B12/CRP Index in Older Systemically Treatable Cancer Patients

M. Baciuchka, P. Villani, L. Greillier, 2021, Cancers.

R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma

E. Pasquier, G. Andelfinger, K. Khosrotehrani, 2019, eLife.

Ultraviolet exposure and risk of melanoma and basal cell carcinoma in Ulm and Dresden, Germany

J. Utikal, M. A. Huber, U. Leiter, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Olaparib and durvalumab in patients with relapsed small cell lung cancer (MEDIOLA): An open-label, multicenter, phase 1/2, basket study.

S. Domchek, Sang-We Kim, M. D. de Jonge, 2023, Lung cancer.

Selpercatinib (LOXO-292) in patients with RET-mutant medullary thyroid cancer.

T. Owonikoko, D. Tan, M. Brose, 2020 .